OMER CIK: 1285819

Omeros Corp.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−110
FY22:
−86.5
FY23:
74.7
FY24:
−149
FY25:
−116
Change from FY21 to FY25
millions USD
FY21:
194
FY22:
−128
FY23:
27.5
FY24:
82.2
FY25:
165
Change from FY21 to FY25
millions USD
FY21:
6.32
FY22:
124
FY23:
−106
FY24:
62.9
FY25:
−42.2
millions USD
FY21:
90.3
FY22:
−89.8
FY23:
−3.90
FY24:
−3.71
FY25:
6.26
(positive)
Change from FY21 to FY25
millions USD
FY21:
−110
FY22:
−86.6
FY23:
74.3
FY24:
−149
FY25:
−116

All amounts in millions USD Data source:SEC EDGAR